Navigation Links
ABQAURP Announces Certificate Course in Medical Error Prevention
Date:9/6/2007

rather than paying more when they occur. Beginning in 2008, Medicare will be allowed to adjust payments for hospital-acquired infections.

Joel V. Brill, MD, AGAF, CHCQM, CME Chair for ABQAURP, notes, "Only in health care, do we continue to pay based on quantity. We don't question whether they are the right services provided to the right person in the right amount in the appropriate setting at the right time. We just pay. And why we should continue to pay more for hospital acquired complications that are largely preventable defies logic."

CMS has indicated they intend to partner with hospitals and other health care organizations in efforts to further address the persistence of "never events." For more information, please visit: http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=1863 . To this end, ABQAURP continues its mission to improve the overall quality of health care provided to the public.

Register for the accredited CME Certificate Course at: http://www.abqaurp.org/course.asp . Course fees: Diplomate $239, Member $299, Non-Member $349.

For 30 years, the American Board of Quality Assurance & Utilization Review Physicians, Inc. (ABQAURP) has been at the nation's forefront in promoting Health Care Quality Management and Patient Safety through education and certification. ABQAURP, a non-profit education and certification board established in 1977, is the nation's largest organization of interdisciplinary health care professionals. ABQAURP is accredited by the ACCME as a provider of Continuing Medical Education. Please visit http://www.abqaurp.org for more information.


'/>"/>
SOURCE ABQAURP
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. PowderMed Announces Needle-Less Flu Vaccine
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
9. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Youngsters who enter puberty early are at increased risk ... was linked with a number of factors associated with ... according to the researchers. Early puberty was also linked ... peers, and having friends who were prone to getting ... found an association between early puberty and these factors, ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Teens prescribed ... to abuse those drugs than other teens, a ... need to conduct substance abuse assessments on teenagers ... said. "Prescribers and parents don,t realize the ... professor at the University of Michigan School of ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Exposure to peanut protein ... allergy in infants with the skin condition eczema, a ... children in the United States are allergic to peanuts. ... food allergies, particularly peanut allergy, the researchers noted. ... to 15 months. The researchers examined the amount of ...
(Date:11/26/2014)... Randy Dotinga HealthDay Reporter ... as Prilosec and Nexium may disrupt the makeup of bacteria ... and other problems, a small new study suggests. ... likely users will become ill, and study authors aren,t recommending ... However, these antacids "should be used at the lowest dose ...
(Date:11/24/2014)... Recently, Fecbek.com ( http://www.fecbek.com ), a leading ... and introduced the history of the Black Friday to its ... after Thanksgiving? It is the Black Friday! It is a ... 11th in China. However, not everyone knows the history of ... about this special day. , The fourth Friday in November ...
Breaking Medicine News(10 mins):Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3
... North Carolina (UNC) at Chapel Hill have revealed that inhaling ... by cystic fibrosis (CF). Hypertonic saline// is a water-based ... ,The researchers arrived at this conclusion after testing 24 patients ... inhaling the salt solution improved the health of the lungs ...
... Pharmaceutical companies have been called upon to stop marketing ... Organization (WHO), as the parasite which causes malaria may ... Kochi, director of the WHO's malaria department, said that ... effective anti-malarials, on its own would result in the ...
... experts have warned that the new wristwatch invented by South ... can turnout to be a health hazard. They have warned ... HIV/AIDS.// There are some who have also expressed doubts if ... ,'In my mind it's a potential public health ...
... 1.107 million fowl have been killed in Turkey with the ... in the country. This has been revealed by the Turkish ... detected in as many as 13 provinces in the country, ... the bird flu has been detected are Van, Aydin, Bursa, ...
... by having their ovaries and uterus removed, if they have ... is because these women face higher chances of contracting ovarian ... as high as 40% to 60%, while it is between ... ,Women who do not have the Lynch syndrome ...
... of African Subcommittee, House Committee on International Relations has ... AIDS testing and counseling as done in Uganda. //Uganda ... effective in early diagnosis of HIV and also helps ... person due to ignorance about the disease. ...
Cached Medicine News:
(Date:11/26/2014)... and LONDON , Nov. 25, 2014 /PRNewswire/ ... AZN ) today announced that AMAGINE-2 TM , ... brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis, ... (ustekinumab) and placebo at week 12. Brodalumab 210 mg ... were each shown to be superior to Stelara on the ...
(Date:11/26/2014)... 2014 / -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ... chain in China based on ... appointment of Ms. Rebecca Yingnan Zhang as ... Ms.Zhang has over 20 years of experience in ... Prior to Ms. Zhang,s appointment as the Company,s Chief ...
(Date:11/24/2014)... SEATTLE , Nov. 24, 2014 ... granted Breakthrough Therapy Designation to the company,s JCAR015 ... for the treatment of relapsed or refractory B-cell ... collaboration partner, Memorial Sloan Kettering Cancer Center, where ... "The FDA,s action is important news ...
Breaking Medicine Technology:Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: